New Research Directions that Advance the NHLBI Strategic Vision Normal Biology (R21 - Clinical Trial Not Allowed)
Deadline: October 16, 2019 05:00 PM
This deadline has passed and is no longer active
The purpose of this Funding Opportunity Announcement (FOA) is to support pilot studies by investigators with current R01-equivalent grant funding in high priority areas of research on normal biology as described by Objective 1 of the NHLBI Strategic Vision. Research on fundamental biological processes that have relevance to multiple HLBS diseases is of particular interest. "Normal" biology includes homeostatic regulation of biological systems and the phenomenon of “resilience” – the capability of some individuals to maintain or restore normal function despite aging or environmental exposures that predispose to disease in others.
Read the full funding opportunity: PA-19-049